Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2002
12/19/2002CA2447658A1 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
12/18/2002EP1266029A1 Diagnosis of a person's risk of developing alcoholism
12/18/2002EP1266022A2 Cell-specific adenovirus vectors comprising an internal ribosome entry site
12/18/2002EP1266015A2 Ecdysone receptor-based inducible gene expression system
12/18/2002EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
12/18/2002EP1266013A2 Heparinase iii and uses thereof
12/18/2002EP1266010A2 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins
12/18/2002EP1266008A2 Acute neuronal induced calcium binding protein type 1 ligand
12/18/2002EP1266006A2 Production of recombinant blood clotting factors in human cell lines
12/18/2002EP1266004A2 Molecules of the pyrin domain protein family and uses thereof
12/18/2002EP1266002A2 Il-17 receptor like molecules and uses thereof
12/18/2002EP1265999A2 Human schizophrenia gene
12/18/2002EP1265996A2 Identification of modulators of the interferon gamma signaling pathway and their use in restenosis treatment
12/18/2002EP1265995A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
12/18/2002EP1265989A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
12/18/2002EP1265924A2 Il-17 receptor like molecules and uses thereof
12/18/2002EP1265922A2 Agonists and antagonists of the receptor gpr19 and their use in appetite control
12/18/2002EP1265920A2 Angiogenesis-associated proteins, and nucleic acids encoding the same
12/18/2002EP1265917A2 Tlp peptides and dna sequences coding the same
12/18/2002EP1265915A2 Novel compounds
12/18/2002EP1265914A2 Wnt-1 related polypeptides, and nucleic acids encoding the same
12/18/2002EP1265910A2 Nucleic acids, proteins, and antibodies
12/18/2002EP1265637A2 Compositions and methods for affecting osteogenesis
12/18/2002EP1265628A1 Use of human not1 and not1a orphan receptors
12/18/2002EP1265627A2 Methods and compositions for inhibiting angiogenesis
12/18/2002EP1265624A1 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof
12/18/2002EP0946721B1 Human growth gene and short stature gene region
12/18/2002EP0736002B9 Compound capable of introducing at least one molecule into a cell
12/18/2002EP0715523B1 Purine nucleoside phosphorylase gene therapy for human malignancy
12/18/2002EP0662150B1 Maspin, a novel serpin with tumor suppressing activity
12/18/2002EP0555370B1 Methods and applications for efficient genetic suppressor elements
12/18/2002CA2388761A1 Wound healing biomarkers
12/17/2002US6495736 Compositions and methods for increasing bone mineralization
12/17/2002US6495663 Method and composition for enhancing transport across biological membranes
12/17/2002US6495662 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
12/17/2002US6495527 Enhancing binding ability of a protein, such as human serum albumin; therapeutic agent carrier
12/17/2002US6495526 Inhibitors of cell-cycle progression and uses related thereto
12/17/2002US6495520 Apoptosis Inducing Molecule II and methods of use
12/17/2002US6495519 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
12/17/2002US6495359 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
12/17/2002US6495349 Chimeric gene constructs
12/17/2002US6495346 Do not react with foreign partners; amino acids inserted into proteins which naturally form dimers, mutated proteins only form complexes with themselves (homodimers) or with the mutated partner (heterodimers), not with nonmutated starting
12/17/2002US6495131 Adenovirus vector
12/17/2002US6495129 Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
12/12/2002WO2002099427A1 Srpks as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099426A1 Pecis as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099140A1 GLRAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099138A2 HS2STs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099125A1 PIBs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099122A1 Modifiers of the p53 pathway and methods of use
12/12/2002WO2002099116A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/12/2002WO2002099108A2 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002WO2002099107A2 Regulation of human trace amine receptor ta5
12/12/2002WO2002099102A1 Numb protein expression inhibitors by musashi
12/12/2002WO2002099101A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
12/12/2002WO2002099097A1 Novel compounds for chemiluminescense procedures
12/12/2002WO2002099096A1 Regulation of human serine/threonine protein kinase-like enzyme
12/12/2002WO2002099094A2 Human serine/threonine protein kinase-like enzyme
12/12/2002WO2002099090A1 Bcl-2 dnazymes
12/12/2002WO2002099083A2 Gfats as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099075A2 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099074A2 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099062A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
12/12/2002WO2002099060A2 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099059A2 U5-200KDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099058A2 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099057A2 Sams modifiers of the p53 pathway and methods of use
12/12/2002WO2002099056A2 C22c7orfs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099055A2 Cips as modifiers of the p53 pathway and method of use
12/12/2002WO2002099054A2 Hccss as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099053A2 Slc22as as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099052A2 Opns as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099051A2 Nits as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099050A2 Tprs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099049A2 Tbc1d1s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099048A2 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099047A2 PROMLs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099046A2 Spo11 as modifier of the p53 pathway and methods of use
12/12/2002WO2002099044A2 B3galts as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099043A2 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099042A2 Cads as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099041A2 Ces2s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099040A2 Igs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099037A2 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
12/12/2002WO2002099036A2 Inhibition of neurodegeneration
12/12/2002WO2002099035A2 Chimeric alphavirus replicon particles
12/12/2002WO2002098916A2 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
12/12/2002WO2002098900A2 Novel human proteins, polynucleotides encoding them and methods of using the same
12/12/2002WO2002098899A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098898A2 FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098890A2 MARKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098467A1 Slc2as as modifiers of the p53 pathway and methods of use
12/12/2002WO2002098466A1 Replicating adenovirus vectors
12/12/2002WO2002098444A2 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
12/12/2002WO2002098443A2 Stabilised mrna with an increased g/c content and optimised codon for use in gene therapy
12/12/2002WO2002098432A1 Methods of treating cardiac disorders
12/12/2002WO2002098424A1 Novel anti-infectives
12/12/2002WO2002098362A2 Use of rank antagonists to treat cancer
12/12/2002WO2002098360A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
12/12/2002WO2002098356A2 Ppp2cs as modifiers of the p53 pathway and methods of use
1 ... 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 ... 870